QA: Globestar Therapeutics Corp in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001502152_2013_Globestar_Therapeutics_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001502152, Globestar Therapeutics Corp

  xvar xval
0 AssetsCurrent 1,359
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 281,264
4 LiabilitiesCurrent 357,618
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 31,139
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 164,345
11 remainder_Revenues 0
12 remainder_NetIncome -944,966
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 282,623
1 Liabilities 388,757
2 Expenses 164,345
3 Revenues 0
4 StockholdersEquity -106,134
5 NetIncome -1,109,311
6 ComprehensiveNetIncome -1,109,311
7 BaseVar 890,346
8 EconomicCapitalRatiobeforeLimitedLiability -3.99
9 EconomicCapitalRatio 0.394

Edgar->Model Mapping

Feature Distribution